Adult cardiopulmonary bypass in the twenty-first century. Science, art or empiricism?;Circulação extracorpórea em adultos no século XXI. Ciência, arte ou empirismo?

Brazilian Journal of Cardiovascular Surgery

Volumn 23, Issue 1, 2008, Pages 78-92

  Mota, André Lupp ^a,b   Rodrigues, Alfredo José ^a,c   Évora, Paulo Roberto Barbosa ^a,b  

^a Departamento de Cirurgia e Anatomia

^b FMRP USP ^*  (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiac surgical procedures; Cardiopulmonary bypass; Extracorporeal circulation

Indexed keywords

METHYLENE BLUE; VASODILATOR AGENT;

ADULT; AGED; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGERY; DIABETES MELLITUS; DRUG EFFECT; EMPIRICISM; EXTRACORPOREAL CIRCULATION; HUMAN; INSTRUMENTATION; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASCULAR RESISTANCE;

ADULT; AGED; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGICAL PROCEDURES; DIABETES MELLITUS; EMPIRICISM; EXTRACORPOREAL CIRCULATION; HUMANS; METHYLENE BLUE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 50449090114     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.1590/S0102-76382008000100013     Document Type: Review

References (47)

1. a ed. 2006. Disponível em: http://perfline.com/livro/index.html
2. Évora PR. CEC: fisiologia e microcirculação. Aula ministrada no 34° Congresso da Sociedade Brasileira de Cirurgia Cardiovascular, Florianópolis; 2007.
3. Barak M, Katz Y. Microbubbles: pathophysiology and clinical implications Chest. 2005;128(4):2918-32.
4. de Vroege R, te Meerman F, Eijsman L, Wildevuur WR, Wildevuur CHR, van Oeveren W, et al. Induction and detection of disturbed homeostasis in cardiopulmonary bypass. Perfusion. 2004;19(5):267-76.
5. rd, Deaton DW, Garb JL, Owen SG. The 'primeless pump': a novel technique for intraoperative blood conservation. Cardiovasc Surg. 1999;7(2):228-35.
6. Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med. 1954;37(3):171-85.
7. Panico FG, Neptune WB. A mechanism to eliminate the donor blood prime from the pump-oxygenator. Surg Forum. 1960;10:605-9.
8. DeBois WJ, Rosengart TK. Retrograde autologous priming reduces blood use. Ann Thorac Surg. 1998;66(3):987-8.
9. Balachandran S, Cross MH, Karthikeyan S, Mulpur A, Hansbro SD, Hobson P. Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery. Ann Thorac Surg. 2002;73(6):1912-8.
10. Dunn J, Kirsh MM, Harness J, Carroll M, Straker J, Sloan H. Hemodynamic, metabolic, and hematologic effects of pulsatile cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1974;68(1):138-47.
11. Reis CL, Evora PR, Ribeiro PJ, Brasil JC, Otaviano AG, Bongiovani HL, et al. Fluxo pulsátil em circulação extracorpórea. Apresentação de um sistema mecânico com estudos preliminares hemodinâmicos e do transporte de oxigênio. Arq Bras Cardiol. 1984;43(4):239-44.
12. Hindman B. Cerebral physiology during cardiopulmonary bypass: pulsatile versus nonpulsatile flow. Adv Pharmacol. 1994;31:607-16.
13. Perthel M, Kseibi S, Sagebiel F, Alken A, Laas J. Comparison of conventional extracorporeal circulation and minimal extracorporeal circulation with respect to microbubbles and microembolic signals. Perfusion. 2005;20(6):329-33.
14. Perthel M, El-Ayoubi L, Bendisch A, Laas J, Gerigk M. Clinical advantages of using mini-bypass systems in terms of blood product use, postoperative bleeding and air entrainment: an in vivo clinical perspective. Eur J Cardiothorac Surg. 2007;31(6):1070-5.
15. Mangoush O, Purkayastha S, Haj-Yahia S, Kinross J, Hayward M, Bartolozzi F, et al. Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. Eur J Cardiothorac Surg. 2007;31(6):1058-69.
16. Campbell EJ, O'Byrne V, Stratford PW, Quirk I, Vick TA, Wiles MC, et al. Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer. ASAIO J. 1994;40(3):M853-7.
17. De Somer F, Francois K, van Oeveren W, Poelaert J, De Wolf D, Ebels T, et al. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. Eur J Cardiothorac Surg. 2000;18(5):602-6.
18. Deppisch R, Göhl H, Smeby L. Microdomain structure of polymeric surfaces- potential for improving blood treatment procedures. Nephrol Dial Transplant. 1998;13(6):1354-9.
19. Tonner PH, Kampen J, Scholz J. Pathophysiological changes in the elderly. Best Pract Res Clin Anaesthesiol. 2003;17(2):163-77.
20. Loran DB, Zwischenberger JB. Thoracic surgery in the elderly. J Am Coll Surg. 2004;199(5):773-84.
21. Matata BM, Galiñanes M. Cardiopulmonary bypass exacerbates oxidative stress but does not increase proinflammatory cytokine release in patients with diabetes compared with patients without diabetes: regulatory effects of exogenous nitric oxide. J Thorac Cardiovasc Surg. 2000;120(1):1-11.
22. Matata BM, Galiñanes M. Effect of diabetes on nitric oxide metabolism during cardiac surgery. Diabetes. 2001;50(11):2603-10.
23. Seghaye MC, Duchateau J, Grabitz RG, Wolff T, Marcus C, Engelhardt W, et al. Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: a clinical and experimental study. J Thorac Cardiovasc Surg. 1996;111(4):882-92.
24. Shanmugam G. Vasoplegic syndrome: the role of methylene blue. Eur J Cardiothorac Surg. 2005;28(5):705-10.
25. Pallas F, Larson DF. Cerebral blood flow in the diabetic patient. Perfusion. 1996;11(5):363-70.
26. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 1997;112(3):676-92.
27. Myles PS, Leong CK, Currey J. Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11(5):571-4.
28. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med. 1997;25(8):1279-82.
29. Argenziano M, Choudhri AF, Oz Mc, Rose EA, Smith CR, Landry DW. A prospective randomised trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation. 1997;96(9 Suppl):II-286-90.
30. Talbot MP, Tremblay I, Denault AY, Bélisle S. Vasopressin for refractory hypotension during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2000;120(2):401-2.
31. Gomes WJ, Carvalho AC, Palma JH, Goncalves I Jr, Buffolo E. Vasoplegic syndrome: a new dilemma. J Thorac Cardiovasc Surg. 1994;107(3):942-3.
32. Andrade JCS, Batista Filho ML, Evora PRB, Tavares JR, Buffolo E, Ribeiro EE, et al. Methylene blue administration in the treatment of the vasoplegic syndrome after cardiac surgery. Rev Bras Cir Cardiovasc. 1996;11(2):107-14.
33. Évora PR. Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock? J Thorac Cardiovasc Surg. 2000;119(3):632-4.
34. Évora PR, Levin RL. Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass.J Thorac Cardiovasc Surg. 2004;127(3):895-6.
35. Évora PR, Viaro F. The guanylyl cyclase inhibition by MB as vasoplegic circulatory shock therapeutical target. Curr Drug Targets. 2006;7(9):1195-204.
36. Leite EG, Ronald A, Rodrigues AJ, Évora PR. Is methylene blue of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome during cardiac surgery? Interact Cardiovasc Thorac Surg. 2006;5(6):774-8.
37. Leyh RG, Kofidis T, Strüber M, Fischer S, Knobloch K, Wachsmann B, et al. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg. 2003;125(6):1426-31.
38. Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, Griotti JJ, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004;77(2):496-9.
39. Ozal E, Kuralay E, Yildirim V, Kilic S, Bolcal C, Kücükarslan N, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005;79(5):1615-9.
40. Fernandes D, Silva-Santos JE, Duma D, Villela CG, Barja-Fidalgo C, Assreuy J. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity. Mol Pharmacol. 2006;69(3):983-90.
41. Schlensak C, Doenst T, Preusser S, Wunderlich M, Kleinschmidt M, Beyersdorf F. Bronchial artery perfusion during cardiopulmonary bypass does not prevent ischemia of the lung in piglets: assessment of bronchial artery blood flow with fluorescent microspheres. Eur J Cardiothorac Surg. 2001;19(3):326-31.
42. Liu Y, Wang Q, Zhu X, Liu D, Pan S, Ruan Y, et al. Pulmonary artery perfusion with protective solution reduces lung injury after cardiopulmonary bypass. Ann Thorac Surg. 2000;69(5):1402-7.
43. Fan X, Liu Y, Wang Q, Yu C, Wei B, Ruan Y. Lung perfusion with clarithromycin ameliorates lung function after cardiopulmonary bypass. Ann Thorac Surg. 2006;81(3):896-901.
44. Gabriel EA. Perfusão do tronco pulmonar em cirurgias cardíacas com emprego de circulação extracorpórea [Tese Pós-Doutorado]. São Paulo:Universidade Federal de São Paulo, Escola Paulista de Medicina;2007.
45. Vohra HA, Levine A, Dunning J. Can ventilation while on cardiopulmonary bypass improve post-operative lung function for patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg. 2005;4(5):442-6.
46. Halstead JC, Etz C, Meier DM, Zhang N, Spielvogel D, Weisz D, et al. Perfusing the cold brain: optimal neuroprotection for aortic surgery. Ann Thorac Surg. 2007;84(3):768-74.
47. Larson DF. Adequacy of perfusion during cardiopulmonary bypass: Empiric or scientific. Disponível em: www.kfshrc.edu.sa/perfusion/education/ Perfusion%20Adequacy%20FINAL%202003.